CYBRD1

cytochrome b reductase 1, the group of Cytochrome b561

Basic information

Region (hg38): 2:171522247-171558129

Links

ENSG00000071967NCBI:79901OMIM:605745HGNC:20797Uniprot:Q53TN4AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • hereditary hemochromatosis (Strong), mode of inheritance: AR

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the CYBRD1 gene.

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the CYBRD1 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
0
missense
15
clinvar
3
clinvar
1
clinvar
19
nonsense
0
start loss
0
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
0
non coding
0
Total 0 0 15 3 1

Variants in CYBRD1

This is a list of pathogenic ClinVar variants found in the CYBRD1 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
2-171522561-T-C not specified Uncertain significance (Jun 30, 2022)2382543
2-171522589-C-T CYBRD1-related disorder Likely benign (Feb 03, 2022)3039228
2-171522648-C-G not specified Uncertain significance (Oct 26, 2021)2410689
2-171522718-T-G not specified Uncertain significance (Apr 12, 2023)2517898
2-171522720-G-A not specified Uncertain significance (Apr 22, 2022)2284997
2-171522723-T-C not specified Uncertain significance (Jan 18, 2023)2461006
2-171541669-C-T not specified Uncertain significance (Dec 17, 2023)3079295
2-171541677-C-T not specified Uncertain significance (Sep 14, 2022)2220941
2-171541683-A-G not specified Uncertain significance (Dec 21, 2023)3079296
2-171541734-A-G not specified Uncertain significance (Jun 21, 2022)2407172
2-171541759-T-C not specified Uncertain significance (Mar 29, 2023)2530941
2-171553387-G-A not specified Likely benign (Mar 07, 2024)3079297
2-171553470-T-C not specified Uncertain significance (Jul 09, 2021)2353963
2-171553471-G-A not specified Uncertain significance (May 16, 2023)2516729
2-171554550-C-T not specified Uncertain significance (Dec 07, 2023)3079298
2-171554604-C-A not specified Uncertain significance (Sep 27, 2021)2252098
2-171554632-G-A not specified Likely benign (Nov 28, 2023)3079299
2-171554763-G-A Benign (Sep 04, 2018)1237711
2-171554814-G-A not specified Uncertain significance (Dec 30, 2023)3079301

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
CYBRD1protein_codingprotein_codingENST00000321348 435887
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.01160.9541257170151257320.0000597
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense0.5891391600.8690.000007871838
Missense in Polyphen3754.410.68002635
Synonymous-0.9247565.51.150.00000357597
Loss of Function1.83511.80.4245.92e-7122

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0002310.000231
Ashkenazi Jewish0.00009930.0000992
East Asian0.000.00
Finnish0.000.00
European (Non-Finnish)0.00004410.0000440
Middle Eastern0.000.00
South Asian0.00003270.0000327
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Ferric-chelate reductase that reduces Fe(3+) to Fe(2+). Present at the brush border of duodenal enterocytes where it probably reduces dietary Fe(3+) thereby facilitating its transport into the mucosal cells. Uses ascorbate as electron donor. May be involved in extracellular ascorbate recycling in erythrocyte membranes. May also act as a ferrireductase in airway epithelial cells. {ECO:0000269|PubMed:16521311, ECO:0000269|PubMed:16521312, ECO:0000269|PubMed:17068337, ECO:0000269|PubMed:19673882}.;
Pathway
Mineral absorption - Homo sapiens (human);Transport of small molecules;Iron uptake and transport (Consensus)

Recessive Scores

pRec
0.183

Intolerance Scores

loftool
0.317
rvis_EVS
0.68
rvis_percentile_EVS
84.93

Haploinsufficiency Scores

pHI
0.103
hipred
N
hipred_score
0.305
ghis
0.389

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
S
essential_gene_gene_trap
N
gene_indispensability_pred
N
gene_indispensability_score
0.200

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Cybrd1
Phenotype
homeostasis/metabolism phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); liver/biliary system phenotype;

Gene ontology

Biological process
cellular iron ion homeostasis;response to iron ion;oxidation-reduction process
Cellular component
lysosomal membrane;plasma membrane;integral component of membrane;brush border membrane;extracellular exosome
Molecular function
ferric-chelate reductase activity;protein binding;oxidoreductase activity;oxidoreductase activity, oxidizing metal ions;metal ion binding